blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2041119

EP2041119 - PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.03.2018
Database last updated on 26.06.2024
FormerThe patent has been granted
Status updated on  07.04.2017
FormerGrant of patent is intended
Status updated on  03.04.2017
FormerExamination is in progress
Status updated on  22.03.2017
FormerGrant of patent is intended
Status updated on  27.11.2016
Most recent event   Tooltip29.05.2020Lapse of the patent in a contracting state
New state(s): PT		published on 01.07.2020  [2020/27]
Applicant(s)For all designated states
Aventis Pharma S.A.
20, avenue Raymond Aron
92160 Antony / FR
[2009/14]
Inventor(s)01 / CHERRIER, Marie-Pierre
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
02 / PARMANTIER, Eric
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
03 / MINOUX, Hervé
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
04 / CLERC, François
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
05 / ANGOUILLANT-BONIFACE, Odile
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
06 / BROLLO, Maurice
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
07 / SCHIO, Laurent
Sanofi-Aventis
Département Brevets
tri E2/300
20 avenue Raymond Aron
92160 Antony / FR
 [2017/19]
Former [2009/14]01 / CHERRIER, Marie-Pierre
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
02 / PARMANTIER, Eric
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
03 / MINOUX, Hervé
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
04 / CLERC, François
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
05 / ANGOUILLANT-BONIFACE, Odile
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
06 / BROLLO, Maurice
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
07 / SCHIO, Laurent
Sanofi-Aventis Département Brevets tri E2/300 20 avenue Raymond Aron
92160 Antony / FR
Representative(s)Lavoix
2, place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
[2017/19]
Former [2011/15]Lavé, Stéphanie, et al
Cabinet Lavoix 2, Place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
Former [2009/14]Le Pennec, Magali, et al
Sanofi-Aventis 20 Avenue Raymond Aron
92165 Antony Cedex / FR
Application number, filing date07803834.603.07.2007
[2009/14]
WO2007FR01126
Priority number, dateFR2006000606404.07.2006         Original published format: FR 0606064
[2009/14]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO2008003857
Date:10.01.2008
Language:FR
[2008/02]
Type: A1 Application with search report 
No.:EP2041119
Date:01.04.2009
Language:FR
The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application.
[2009/14]
Type: B1 Patent specification 
No.:EP2041119
Date:10.05.2017
Language:FR
[2017/19]
Search report(s)International search report - published on:EP10.01.2008
ClassificationIPC:C07D403/04, C07D413/14, C07D403/14, C07D405/14, A61K31/551, A61K31/4184, A61K31/5377, A61K31/496, A61P35/00
[2009/14]
CPC:
C07D403/04 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/04 (EP);
A61P13/02 (EP); A61P13/08 (EP); A61P13/10 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P15/08 (EP);
A61P15/14 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P25/00 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/10 (EP); A61P5/14 (EP); A61P5/38 (EP);
A61P9/00 (EP); C07D235/04 (EP,US); C07D401/14 (EP,US);
C07D403/14 (EP,US); C07D405/14 (EP,US); C07D413/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/19]
Former [2009/14]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL04.02.2009
BA04.02.2009
HR04.02.2009
MK04.02.2009
RS04.02.2009
TitleGerman:PYRAZOLYLBENZIMIDAZOLDERIVATE, DIESE ENTHALTENDE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG[2009/14]
English:PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF[2009/14]
French:DERIVES DE PYRAZOLYLBENZIMIDAZOLE, COMPOSITIONS LES CONTENANT ET LEUR UTILISATION[2009/14]
Entry into regional phase04.02.2009National basic fee paid 
04.02.2009Designation fee(s) paid 
04.02.2009Examination fee paid 
Examination procedure05.05.2008Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.02.2009Examination requested  [2009/14]
12.07.2010Despatch of a communication from the examining division (Time limit: M06)
14.01.2011Reply to a communication from the examining division
13.03.2012Despatch of a communication from the examining division (Time limit: M04)
10.07.2012Reply to a communication from the examining division
24.02.2014Despatch of a communication from the examining division (Time limit: M04)
23.06.2014Reply to a communication from the examining division
24.06.2015Despatch of a communication from the examining division (Time limit: M04)
04.09.2015Reply to a communication from the examining division
04.03.2016Despatch of a communication from the examining division (Time limit: M04)
15.04.2016Reply to a communication from the examining division
28.11.2016Communication of intention to grant the patent
16.03.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
16.03.2017Fee for grant paid
16.03.2017Fee for publishing/printing paid
03.04.2017Information about intention to grant a patent
03.04.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.07.2010
Opposition(s)13.02.2018No opposition filed within time limit [2018/16]
Fees paidRenewal fee
10.07.2009Renewal fee patent year 03
14.07.2010Renewal fee patent year 04
12.07.2011Renewal fee patent year 05
13.07.2012Renewal fee patent year 06
10.07.2013Renewal fee patent year 07
14.07.2014Renewal fee patent year 08
10.07.2015Renewal fee patent year 09
11.07.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.07.2007
AT10.05.2017
CY10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MT10.05.2017
NL10.05.2017
PL10.05.2017
PT10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
TR10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
[2020/27]
Former [2020/15]HU03.07.2007
AT10.05.2017
CY10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MT10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
TR10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2019/46]HU03.07.2007
AT10.05.2017
CY10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MT10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2019/31]HU03.07.2007
AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MT10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2019/30]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
MC10.05.2017
MT10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/43]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
MT10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/39]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
LU03.07.2017
BE31.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/34]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
LU03.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/23]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SI10.05.2017
SK10.05.2017
IE03.07.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/21]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SK10.05.2017
CH31.07.2017
LI31.07.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/11]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
IT10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SK10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/10]AT10.05.2017
CZ10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
RO10.05.2017
SE10.05.2017
SK10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2018/09]AT10.05.2017
DK10.05.2017
EE10.05.2017
ES10.05.2017
FI10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
SE10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2017/52]AT10.05.2017
ES10.05.2017
FI10.05.2017
LT10.05.2017
LV10.05.2017
NL10.05.2017
PL10.05.2017
SE10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2017/50]AT10.05.2017
ES10.05.2017
FI10.05.2017
LT10.05.2017
LV10.05.2017
PL10.05.2017
SE10.05.2017
BG10.08.2017
GR11.08.2017
IS10.09.2017
Former [2017/49]AT10.05.2017
ES10.05.2017
FI10.05.2017
LT10.05.2017
GR11.08.2017
IS10.09.2017
Cited inInternational search[DX]WO2005002552  (ASTEX TECHNOLOGY LTD [GB], et al) [DX] 1-30 * claim 1 * * page 158; examples 87,88 *;
 [DX]WO03035065  (AVENTIS PHARMA INC [US], et al) [DX] 1-30 * claim 1 * * page 446 - page 448; examples 257-c,257-d,257-e,257-h,257-i * * page 450 - page 452; examples 258-d,258-e,258-h * * page 459 - page 460; examples 260-d,260-f,260-g *
Examination   - G.A. PATANI ET AL., "Bioisosterism: A Rational Approach in Drug Design", CHEM. REV., (1996), vol. 96, doi:doi:10.1021/cr950066q, pages 3147 - 3176, XP000652176

DOI:   http://dx.doi.org/10.1021/cr950066q
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.